Up a level |
Tansley, Sarah L, Simou, Stefania, Shaddick, Gavin, Betteridge, Zoe E, Almeida, Beverley, Gunawardena, Harsha, Thomson, Wendy, Beresford, Michael W ORCID: 0000-0002-5400-9911, Midgle, Angela, Muntoni, Francesco et al (show 2 more authors)
(2017)
Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.
JOURNAL OF AUTOIMMUNITY, 84.
pp. 55-64.
Sampath, Sunil, Sergeant, Jamie C, Viatte, Sebastien, Carrasco, Roberto, Cobb, Joanna, Smith, Samantha, Hinks, Anne, Wedderburn, Lucy R, Beresford, Michael W ORCID: 0000-0002-5400-9911, Hyrich, Kimme L et al (show 1 more authors)
(2016)
Clinical Factors Associated with Non-Response to Methotrexate in Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis Response to Treatment Consortium.
.
Tansley, Sarah L, Tansley, Sarah L, Dunphy, Juliet, Jobling, Amelia AC, Carrasco, Roberto, Midgley, Angela, Beresford, Michael ORCID: 0000-0002-5400-9911, Dick, Andrew D, Wedderburn, Lucy R, Thomson, Wendy et al (show 2 more authors)
(2016)
A DENSE FINE SPECKLE PATTERN ON IMMUNOFLUORESCENCE IS STRONGLY ASSOCIATED WITH THE DEVELOPMENT OF UVEITIS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS.
.
Lilleker, James B, Vencovsky, Jiri, Wang, Guochun, Wedderburn, Lucy R, Diederichsen, Louise Pyndt, Schmidt, Jens, Oakley, Paula, Benveniste, Olivier, Danieli, Maria Giovanna, Danko, Katalin et al (show 17 more authors)
(2018)
The EuroMyositis registry: an international collaborative tool to facilitate myositis research.
ANNALS OF THE RHEUMATIC DISEASES, 77 (1).
pp. 30-39.
Shoop-Worrall, Stephanie JW ORCID: 0000-0002-9441-5535, Hyrich, Kimme L ORCID: 0000-0001-8242-9262, Wedderburn, Lucy R ORCID: 0000-0002-7495-1429, Thomson, Wendy, Geifman, Nophar ORCID: 0000-0003-2956-6676 and CAPS the CLUSTER Consortium,
(2021)
Patient-reported wellbeing and clinical disease measures over time captured by multivariate trajectories of disease activity in individuals with juvenile idiopathic arthritis in the UK: a multicentre prospective longitudinal study.
The Lancet. Rheumatology, 3 (2).
e111-e121.